Insulin aspart, recombinant Subcutaneous and Methocarbamol Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Methocarbamol Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: methocarbamol
Brand name: Robaxin, Robaxin-750, Carbacot, Skelex
Synonyms: Methocarbamol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Methohexital
- Insulin aspart, recombinant Subcutaneous-Methotrexate
- Insulin aspart, recombinant Subcutaneous-Methotrexate injection
- Insulin aspart, recombinant Subcutaneous-Methotrexate Injection (Subcutaneous)
- Insulin aspart, recombinant Subcutaneous-Methotrexate Oral Solution
- Insulin aspart, recombinant Subcutaneous-Methotrexate Oral, Injection
- Methocarbamol Tablets-Insulin degludec
- Methocarbamol Tablets-Insulin Degludec (U-100) Prefilled Pens
- Methocarbamol Tablets-Insulin Degludec (U-100) Vials
- Methocarbamol Tablets-Insulin Degludec (U-200) Prefilled Pens
- Methocarbamol Tablets-Insulin degludec and liraglutide
- Methocarbamol Tablets-Insulin degludec and liraglutide Subcutaneous